Our mission is to discover drugs for high unmet medical needs that will improve quality of life for patients with Orphan Diseases.

We stand out by our ability to deliver high value products with relatively little cost in a short period of time. Due to our business model we reduce the risk of drug development.

SOM Biotech has a strong pipeline of products focused on Orphan diseases at preclinical and clinical stages.